3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
641
Glioblastoma
573
Glioma
409
Neuroblastoma
174
Neoplasms
125
Astrocytoma
108
Central Nervous System Neoplasms
105
Medulloblastoma
89
Breast Neoplasms
86
Meningioma
84
Carcinoma, Non-Small-Cell Lung
78
Melanoma
77
Lung Neoplasms
69
Sarcoma
66
Ependymoma
65
Neurofibromatosis 1
63
Recurrence
50
Oligodendroglioma
48
Neoplasm Metastasis
48
Osteosarcoma
47
Meningeal Carcinomatosis
46
Diffuse Intrinsic Pontine Glioma
46
Rhabdomyosarcoma
45
Pheochromocytoma
44
Paraganglioma
42
Rhabdoid Tumor
41
Gliosarcoma
40
Sarcoma, Ewing
39
Pancreatic Neoplasms
39
Colorectal Neoplasms
33
Interventions
Granulocyte-Macrophage Colony-Stimulating Factor
1
Diphtheria-Tetanus Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Xanthomatosis, Cerebrotendinous
×
CNS
×
1 year
×
Clear all
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled